N-of-One

Curated by Signal

Molecular profiling and analysis for hospitals

Overview

N-of-One is a molecular decision support company providing clinicians with clinically meaningful interpretation of molecular test results. It analyzes and interprets tumor molecular profiles to help physicians identify diagnostic and treatment strategies. Solutions offered: Precision Insights, a case-specific report for NGS panels and TrialMatch, uses patient’s molecular data to identify the best clinical trial options for patients. The company claims it provides decision support service to physicians and that it is not a diagnostic laboratory or a bioinformatics company.

Key facts

Founded: 2008
Headquarters: Lexington, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

GTM channel: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Novela Neurotechnologies
Developer of neural implants to monitor, diagnose and treat the neurological disorders
Life Sciences TechnologyAlameda, United States
Forome Association
Provider of a software solution for genomic sequencing
Life Sciences TechnologyBoston, United States
Hi5 cannabis
Provider of cannabis-infused nutritional drinks
Life Sciences TechnologyStoneham, United States

About N-of-One

What does N-of-One do?

N-of-One is a molecular decision support company providing clinicians with clinically meaningful interpretation of molecular test results.

Where is N-of-One headquartered?

N-of-One is headquartered in Lexington, United States.

When was N-of-One founded?

N-of-One was founded in 2008.

Which sector is N-of-One in?

N-of-One operates in Life Sciences Technology.

Who are N-of-One's competitors?

Companies similar to N-of-One include Novela Neurotechnologies, Forome Association, and Hi5 cannabis.